Etanercept, a soluble recombinant tumor necrosis factor (TNF) receptor fusion protein, is indicated for the treatment of rheumatoid arthritis (RA), psoriatic arthritis, and ankylosing spondylitis. …
A new study published in the journal of allergy and clinical immunology has reported that anti-interleukin-1 receptor antagonist (IL-1RA) autoantibodies in patients with IgG4-RD can …
A recent retrospective study carried out in an ophthalmology clinic in north Karnataka has noted that anterior uveitis of noninfectious etiology is more frequent in …
A study published in the American college of rheumatology Open Rheumatology has concluded that the human leukocyte antigen-B27(HLA-B27) status is not predictive of biologic disease-modifying …
Peripheral blood neutrophil-lymphocyte ratio (NLR) and lymphocyte-monocyte ratio (LMR) can act as biological indicators in predicting renal function and prognosis in patients with lupus nephritis, …
The findings of a nested case-control study published in the journal of Neurology have concluded that the use of disease-modifying antirheumatic drugs (DMARDs) does not …
Recent study findings, published in Arthritis Care & Research, have shown that patients with dermatomyositis-specific autoantibodies achieved better levels of treatment response compared to other autoantibody-defined …
Interstitial lung disease (ILD), an extra-articular manifestation noted in nearly 11% of RA patients, is a major cause for poor prognosis noted in this population …
A new study published in Experimental & Molecular Medicine, led by researchers from the Catholic University of Korea, Seoul National University, and Soonchunhyang University College …